LoSQINCT07908108
Cross-cultural Adaptation and Validation of the Localised Scleroderma Quality of Life Instrument (LoSQI) in Juvenile Localised Scleroderma (JLS)
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 1 version: 1 with changes below.
- Study First Submitted
Endpoints
Primary
Adaptation
Timeframe: baseline and 4 months (+/- 2 months)
Sites
33 sites in 19 countries
Brazil 4, Italy 4, United Kingdom 4, Norway 3, Turkey (Türkiye) 3, Netherlands 2, Argentina 1, China 1, Croatia 1, Denmark 1, Egypt 1, Germany 1, Greece 1, India 1, Latvia 1, Poland 1, Singapore 1, Slovakia 1, Spain 1